Drug
Trastuzumab
Trastuzumab: highest development phase Phase 3, developed by Chugai. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Chugai
Trials
| Drug | Phase | Indication |
|---|---|---|
| Trastuzumab NCT02514681 | Phase 3 | HER2-positive Locally Advanced or Metastatic Breast Cancer |
Latest
No recent events.
Follow Trastuzumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.